Correlation between peripheral-blood leukocyte expression of CD25, CD4, and 38 surface markers
Staining pattern versus CD25*for cells gated for expression of CD4† . | Antibodies . |
|---|---|
| All cells negative or very low | CD8†, CD21‡, CD23‡, CD40L†, CD54†, CD70§, CD74†, CD84†, CXCR5†, CD148∥ |
| Large negative population, including all CD25+ cells | CD56†, CD95L†, CD244§, CXCR4† |
| All cells positive | CD3† |
| Most cells positive, including all CD25+ cells | CD5†, CD11a¶, CD28#, CD57† |
| CD27‡, CD38†, CD44†, CD45RA†, CD45RO†, CD58†, CD62L†, CD71†, CD95†, | |
| Profiles shown in Figure 2 | CTLA-4 (CD152)†, HLA-DR†, CCR7† |
| Resembles that of GITR (Figure 2A) | OX40 (CD134)†, GITR**, CD30#, CD69†, CD103†, CD122†, CD150∥ |
Staining pattern versus CD25*for cells gated for expression of CD4† . | Antibodies . |
|---|---|
| All cells negative or very low | CD8†, CD21‡, CD23‡, CD40L†, CD54†, CD70§, CD74†, CD84†, CXCR5†, CD148∥ |
| Large negative population, including all CD25+ cells | CD56†, CD95L†, CD244§, CXCR4† |
| All cells positive | CD3† |
| Most cells positive, including all CD25+ cells | CD5†, CD11a¶, CD28#, CD57† |
| CD27‡, CD38†, CD44†, CD45RA†, CD45RO†, CD58†, CD62L†, CD71†, CD95†, | |
| Profiles shown in Figure 2 | CTLA-4 (CD152)†, HLA-DR†, CCR7† |
| Resembles that of GITR (Figure 2A) | OX40 (CD134)†, GITR**, CD30#, CD69†, CD103†, CD122†, CD150∥ |
Obtained from BD Biosciences, San Jose, CA
Obtained from PharMingen
Obtained from Ancell, Bayport, MN
Obtained from Immunotech, Marseille, France
Obtained from DNAX Research Institute, Palo Alto, CA
Obtained from Caltag, Burlingame, CA
Obtained from Miltenyi Biotec, Gladbach, Germany
Obtained from R&D Systems, Minneapolis, MN